Table 2.
Effects of systemic nicotine treatment on KYNA levels in different areas of the rat brain
| KYNA (fmol/mg protein) | |||
|---|---|---|---|
| Striatum | Hippocampus | Frontal cortex | |
| 5 d | |||
| Control | 137 ± 9 | 180 ± 19 | 209 ± 14 |
| Nicotine | 103 ± 4* | 118 ± 7* | 141 ± 9* |
| Δ (%) | 75 | 66 | 67 |
| 15 d | |||
| Control | 154 ± 8 | 181 ± 7 | 199 ± 4 |
| Nicotine | 191 ± 10* | 213 ± 7* | 227 ± 10* |
| Δ (%) | 124 | 118 | 114 |
Nicotine (1 mg/kg, s.c.) was administered every 12 h for 5 or 15 d, and animals were killed 1 h after the last injection. KYNA levels were determined as described in Materials and Methods. Results are presented as mean ± SEM (n = 5 animals in each treatment).
p < 0.05 versus PBS-injected controls (repeated-measures ANOVA followed by Bonferroni's post hoctest for multiple comparisons).